C-probe libraries for DNA target enrichment

US10150960B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10150960-B2
Application numberUS-201313777842-A
CountryUS
Kind codeB2
Filing dateFeb 26, 2013
Priority dateFeb 26, 2013
Publication dateDec 11, 2018
Grant dateDec 11, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein is a method for enriching a target nucleic acid molecule. In one embodiment, the method may involve hybridizing a C-probe to a strand of a target nucleic acid to produce a complex, enzymatically removing any 3′ overhanging end from the target nucleic acid of the complex to produce a 3′ hydroxyl group at the 3′ end; extending the 3′ end of the first sequence using the oligonucleotide sequence of the C-probe as a template; enzymatically removing any 5′ overhanging end from the target nucleic acid, either before or after the extending step, to produce an 5′ phosphate group at the end of the second sequence; and ligating the 5′ phosphate group at the end of the second sequence to the 3′ hydroxyl group at the end of the first sequence to produce a circular DNA molecule that contains the target sequence and the complement of the oligonucleotide sequence.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of processing a nucleic acid, comprising: (a) hybridizing a C-probe to a strand of a target nucleic acid to produce a complex, wherein: (i) said strand comprises a target sequence that is flanked by a first sequence and a second sequence, and (ii) said C-probe comprises a first region that hybridizes to said first sequence, a second region that hybridizes to said second sequence, and an oligonucleotide sequence between said first and second regions, (b) enzymatically removing any 3′ overhang from the target nucleic acid of said complex to produce a 3′ hydroxyl group at the 3′ end of said first sequence; (c) extending the 3′ end of said first sequence using the oligonucleotide sequence of said C-probe as a template, wherein said extending results in a 3′ hydroxyl group that is adjacent to the 5′ end of said second sequence; (d) enzymatically removing any 5′ overhanging from the target nucleic acid, either before or after said extending of step (c), to produce a 5′ phosphate group at the end of said second sequence; and (e) ligating the 5′ phosphate group at the end of the second sequence to the 3′ hydroxyl group that is adjacent to the 5′ end of said second sequence to produce a circular DNA molecule that contains said target sequence and the complement of said oligonucleotide sequence. 2. The method of claim 1 , wherein said method comprises: (f) amplifying the target sequence from said circular DNA molecule using one or more primers that either hybridize with or have the same sequence as sites in the oligonucleotide sequence. 3. The method of claim 2 , further comprising: (g) sequencing the amplification product of (f) to provide the nucleotide sequence of at least part of the target sequence. 4. The method of claim 1 , wherein the 5′ overhanging end of the target nucleic acid is enzymatically removed before step (c). 5. The method of claim 4 , wherein the 3′ and 5′ overhanging ends of the target nucleic acid are enzymatically removed using a single-strand specific bi-directional exonuclease, optionally in the presence of a polymerase. 6. The method of claim 5 , wherein said single-strand specific bi-directional exonuclease is exonuclease VII. 7. The method of claim 4 , wherein said C-probe is designed to provide G-A mismatches in the complex, and the 3′ and 5′ overhanging ends of the target nucleic acid are enzymatically removed using glycosylase and AP endonuclease activities. 8. The method of claim 4 , wherein the 3′ and 5′ overhanging ends of the target nucleic acid are enzymatically removed using exonuclease T and T7 exonuclease. 9. The method of claim 1 , wherein the 5′ overhanging end of the target nucleic acid is enzymatically removed after step (c). 10. The method of claim 1 , wherein: the 3′ overhanging end of the target nucleic acid is enzymatically removed by the exonuclease activity of T4 DNA polymerase; said extending step (c) is done using the polymerase activity of T4 DNA polymerase; and the 3′ overhanging end of the target nucleic acid is enzymatically removed by a flap endonuclease. 11. The method of claim 1 , wherein the oligonucleotide sequence comprises a molecular barcode. 12. The method of claim 1 , wherein said target nucleic acid is genomic DNA. 13. The method of claim 12 , wherein the genomic DNA is randomly sheared genomic DNA that has been produced using a chemical, physical or transposase-catalyzed fragmentation method. 14. The method of claim 1 , wherein the 3′ overhanging end of the target nucleic acid is enzymatically removed by a nicking endonuclease. 15. The method of claim 1 , wherein the 5′ overhanging end of the target nucleic acid is enzymatically removed by a nicking endonuclease. 16. The method of claim 1 , wherein said target sequence is in the range of 10 nt to 1,000 nt in length. 17. The method of claim 1 , wherein the region extended in step (c) is composed of no more than three different nucleotides. 18. The method of claim 1 , wherein the 3′ end of said C-probe is blocked to prevent the addition of nucleotides by a polymerase or a ligase. 19. The method of claim 18 , wherein the 3′ end of said C-probe comprises a dideoxy nucleotide and a phosphothioate linkage. 20. A kit for processing a target nucleic acid, comprising: a C-probe comprising a first region that hybridizes to a first sequence in a strand of said target nucleic acid, a second region that hybridizes to a second sequence in said strand, and an oligonucleotide sequence between said first and second regions, wherein the 3′ end of said C-probe is blocked to prevent the addition of nucleotides by a polymerase or a ligase, one or more enzymes that remove 5′ and 3′ single stranded overhangs; and a DNA ligase.

Assignees

Inventors

Classifications

  • C12N15/10Primary

    Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10150960B2 cover?
Provided herein is a method for enriching a target nucleic acid molecule. In one embodiment, the method may involve hybridizing a C-probe to a strand of a target nucleic acid to produce a complex, enzymatically removing any 3′ overhanging end from the target nucleic acid of the complex to produce a 3′ hydroxyl group at the 3′ end; extending the 3′ end of the first sequence using the oligonucleo…
Who is the assignee on this patent?
Agilent Technologies Inc
What technology area does this patent fall under?
Primary CPC classification C12N15/10. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).